vs
Side-by-side financial comparison of Spero Therapeutics, Inc. (SPRO) and SPRUCE POWER HOLDING CORP (SPRU). Click either name above to swap in a different company.
SPRUCE POWER HOLDING CORP is the larger business by last-quarter revenue ($24.0M vs $12.6M, roughly 1.9× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -28.6%, a 279.2% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 20.4%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 14.6%).
Spruce Finance is an American consumer finance company specializing in the residential solar finance and efficiency home improvement sectors in the U.S.
SPRO vs SPRU — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.6M | $24.0M |
| Net Profit | $31.5M | $-6.9M |
| Gross Margin | — | — |
| Operating Margin | — | 9.4% |
| Net Margin | 250.7% | -28.6% |
| Revenue YoY | 24080.8% | 20.4% |
| Net Profit YoY | 250.9% | -15.8% |
| EPS (diluted) | $0.56 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.6M | $24.0M | ||
| Q3 25 | $0 | $30.7M | ||
| Q2 25 | $0 | $33.2M | ||
| Q1 25 | $12.0K | $23.8M | ||
| Q4 24 | $52.0K | $20.0M | ||
| Q3 24 | $65.0K | $21.4M | ||
| Q2 24 | $114.0K | $22.5M | ||
| Q1 24 | $140.0K | $18.3M |
| Q4 25 | $31.5M | $-6.9M | ||
| Q3 25 | $-7.4M | $-860.0K | ||
| Q2 25 | $-1.7M | $-3.0M | ||
| Q1 25 | $-13.9M | $-15.3M | ||
| Q4 24 | — | $-5.9M | ||
| Q3 24 | $-17.1M | $-53.5M | ||
| Q2 24 | $-17.9M | $-8.6M | ||
| Q1 24 | $-12.7M | $-2.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.8% | ||
| Q2 24 | — | 54.9% | ||
| Q1 24 | — | 51.5% |
| Q4 25 | — | 9.4% | ||
| Q3 25 | — | 27.6% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | -122758.3% | -7.1% | ||
| Q4 24 | — | -31.4% | ||
| Q3 24 | -28604.6% | -173.8% | ||
| Q2 24 | -16720.2% | -14.9% | ||
| Q1 24 | -9987.1% | -19.7% |
| Q4 25 | 250.7% | -28.6% | ||
| Q3 25 | — | -2.8% | ||
| Q2 25 | — | -8.9% | ||
| Q1 25 | -115550.0% | -64.4% | ||
| Q4 24 | — | -29.7% | ||
| Q3 24 | -26380.0% | -250.4% | ||
| Q2 24 | -15668.4% | -38.2% | ||
| Q1 24 | -9049.3% | -13.4% |
| Q4 25 | $0.56 | $-0.38 | ||
| Q3 25 | $-0.13 | $-0.05 | ||
| Q2 25 | $-0.03 | $-0.17 | ||
| Q1 25 | $-0.25 | $-0.84 | ||
| Q4 24 | — | $-0.36 | ||
| Q3 24 | $-0.32 | $-2.88 | ||
| Q2 24 | $-0.33 | $-0.45 | ||
| Q1 24 | $-0.24 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.3M | $54.8M |
| Total DebtLower is stronger | — | $695.5M |
| Stockholders' EquityBook value | $59.0M | $121.3M |
| Total Assets | $68.9M | $837.3M |
| Debt / EquityLower = less leverage | — | 5.74× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.3M | $54.8M | ||
| Q3 25 | $48.6M | $53.6M | ||
| Q2 25 | $31.2M | $53.5M | ||
| Q1 25 | $48.9M | $61.9M | ||
| Q4 24 | $52.9M | $72.8M | ||
| Q3 24 | $76.3M | $113.7M | ||
| Q2 24 | $63.5M | $116.6M | ||
| Q1 24 | $82.3M | $120.6M |
| Q4 25 | — | $695.5M | ||
| Q3 25 | — | $705.6M | ||
| Q2 25 | — | $717.1M | ||
| Q1 25 | — | $723.8M | ||
| Q4 24 | — | $730.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $59.0M | $121.3M | ||
| Q3 25 | $26.5M | $124.9M | ||
| Q2 25 | $32.8M | $125.0M | ||
| Q1 25 | $33.8M | $130.8M | ||
| Q4 24 | $46.1M | $143.7M | ||
| Q3 24 | $65.5M | $151.6M | ||
| Q2 24 | $80.5M | $204.6M | ||
| Q1 24 | $96.2M | $213.0M |
| Q4 25 | $68.9M | $837.3M | ||
| Q3 25 | $54.2M | $857.1M | ||
| Q2 25 | $62.1M | $862.6M | ||
| Q1 25 | $77.7M | $878.0M | ||
| Q4 24 | $110.5M | $898.5M | ||
| Q3 24 | $135.2M | $806.8M | ||
| Q2 24 | $149.9M | $858.4M | ||
| Q1 24 | $167.7M | $867.9M |
| Q4 25 | — | 5.74× | ||
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 5.74× | ||
| Q1 25 | — | 5.53× | ||
| Q4 24 | — | 5.08× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.4M | $-3.3M |
| Free Cash FlowOCF − Capex | — | $-3.3M |
| FCF MarginFCF / Revenue | — | -13.7% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | -0.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-3.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.4M | $-3.3M | ||
| Q3 25 | $17.4M | $11.2M | ||
| Q2 25 | $-17.7M | $-2.3M | ||
| Q1 25 | $-4.0M | $-9.1M | ||
| Q4 24 | $-23.4M | $-13.5M | ||
| Q3 24 | $12.8M | $-1.1M | ||
| Q2 24 | $-18.7M | $-5.1M | ||
| Q1 24 | $5.9M | $-22.2M |
| Q4 25 | — | $-3.3M | ||
| Q3 25 | — | $11.2M | ||
| Q2 25 | — | $-2.4M | ||
| Q1 25 | — | $-9.2M | ||
| Q4 24 | — | $-13.6M | ||
| Q3 24 | — | $-1.1M | ||
| Q2 24 | — | $-5.2M | ||
| Q1 24 | — | $-22.3M |
| Q4 25 | — | -13.7% | ||
| Q3 25 | — | 36.5% | ||
| Q2 25 | — | -7.3% | ||
| Q1 25 | — | -38.7% | ||
| Q4 24 | — | -68.3% | ||
| Q3 24 | — | -5.1% | ||
| Q2 24 | — | -23.1% | ||
| Q1 24 | — | -121.7% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | -0.26× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
